Literature DB >> 12531344

Costs and benefits of polio eradication: a long-run global perspective.

M Mahmud Khan1, Jennifer Ehreth.   

Abstract

Pre-vaccination polio incidence rates in USA and Italy were used to predict the cases that would have occurred in the world for the years 1970-2050 in the absence of immunization. Globally, polio program will cost about US dollars 67 billion if vaccination is discontinued after 2010. The medical care cost savings achieved will be more than US dollars 128 billions, implying that polio eradication activities actually pay for itself in the longer run. In addition to the cost savings, the program will prevent 855000 deaths, 4 million paralysis cases and 40 million disability adjusted life years (DALYs) over the years 1970-2050.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12531344     DOI: 10.1016/s0264-410x(02)00584-4

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  13 in total

1.  Global efforts to eradicate polio.

Authors:  Valerie F Krym; Russell D MacDonald
Journal:  CMAJ       Date:  2004-01-20       Impact factor: 8.262

2.  Economic considerations for the eradication endgame.

Authors:  Scott Barrett
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-06-24       Impact factor: 6.237

3.  The risks, costs, and benefits of possible future global policies for managing polioviruses.

Authors:  Kimberly M Thompson; Radboud J Duintjer Tebbens; Mark A Pallansch; Olen M Kew; Roland W Sutter; R Bruce Aylward; Margaret Watkins; Howard E Gary; James Alexander; Hamid Jafari; Stephen L Cochi
Journal:  Am J Public Health       Date:  2008-05-29       Impact factor: 9.308

4.  Reactive attachment disorder: a preventable mental health disease.

Authors:  James J Lehman; Shereen K Jegtvig
Journal:  J Chiropr Med       Date:  2004

5.  Health and Economic Outcomes Associated with Polio Vaccine Policy Options: 2019-2029.

Authors:  Dominika A Kalkowska; Kimberly M Thompson
Journal:  Risk Anal       Date:  2021-02       Impact factor: 4.000

Review 6.  Costs and financial feasibility of malaria elimination.

Authors:  Oliver Sabot; Justin M Cohen; Michelle S Hsiang; James G Kahn; Suprotik Basu; Linhua Tang; Bin Zheng; Qi Gao; Linda Zou; Allison Tatarsky; Shahina Aboobakar; Jennifer Usas; Scott Barrett; Jessica L Cohen; Dean T Jamison; Richard G A Feachem
Journal:  Lancet       Date:  2010-10-28       Impact factor: 79.321

7.  The potential impact of immunization campaign budget re-allocation on global eradication of paediatric infectious diseases.

Authors:  Tiffany Fitzpatrick; Chris T Bauch
Journal:  BMC Public Health       Date:  2011-09-28       Impact factor: 3.295

Review 8.  Can Economic Analysis Contribute to Disease Elimination and Eradication? A Systematic Review.

Authors:  Elisa Sicuri; David B Evans; Fabrizio Tediosi
Journal:  PLoS One       Date:  2015-06-12       Impact factor: 3.240

9.  Supplementary immunization activities (SIAs) in South Africa: comprehensive economic evaluation of an integrated child health delivery platform.

Authors:  Stéphane Verguet; Waasila Jassat; Melanie Y Bertram; Stephen M Tollman; Christopher J L Murray; Dean T Jamison; Karen J Hofman
Journal:  Glob Health Action       Date:  2013-03-01       Impact factor: 2.640

10.  An economic analysis of poliovirus risk management policy options for 2013-2052.

Authors:  Radboud J Duintjer Tebbens; Mark A Pallansch; Stephen L Cochi; Steven G F Wassilak; Kimberly M Thompson
Journal:  BMC Infect Dis       Date:  2015-09-24       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.